B. Yosef, N. Kaddar, and A. Boubou, “Evaluation of the Effect of Dapagliflozin on CRP Levels in Type 2 Diabetes Patients”, Jordan j. pharm. sci., vol. 16, no. 2, pp. 313–321, Jun. 2023.